Search Results - "Cole, Graham D."

Refine Results
  1. 1

    The impact of artificial intelligence on clinical education: perceptions of postgraduate trainee doctors in London (UK) and recommendations for trainers by Banerjee, Maya, Chiew, Daphne, Patel, Keval T, Johns, Ieuan, Chappell, Digby, Linton, Nick, Cole, Graham D, Francis, Darrel P, Szram, Jo, Ross, Jack, Zaman, Sameer

    Published in BMC medical education (14-08-2021)
    “…Artificial intelligence (AI) technologies are increasingly used in clinical practice. Although there is robust evidence that AI innovations can improve patient…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: Recommendations for patient information by Barron, Anthony J, Zaman, Nabeela, Cole, Graham D, Wensel, Roland, Okonko, Darlington O, Francis, Darrel P

    Published in International journal of cardiology (09-10-2013)
    “…Abstract Background Patients trying life-preserving agents such as beta-blockers may be discouraged by listings of harmful effects provided in good faith by…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    The effect of concomitant COVID‐19 infection on outcomes in patients hospitalized with heart failure by Chatrath, Nikhil, Kaza, Nandita, Pabari, Punam A., Fox, Kevin, Mayet, Jamil, Barton, Carys, Cole, Graham D., Plymen, Carla M.

    Published in ESC Heart Failure (01-12-2020)
    “…Aims Patients with cardiovascular disease appear particularly susceptible to severe COVID‐19 disease, but the impact of COVID‐19 infection on patients with…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery by Bouri, Sonia, Shun-Shin, Matthew James, Cole, Graham D, Mayet, Jamil, Francis, Darrel P

    Published in Heart (British Cardiac Society) (01-03-2014)
    “…Current European and American guidelines recommend the perioperative initiation of a course of β-blockers in those at risk of cardiac events undergoing high-…”
    Get more information
    Journal Article
  13. 13

    Urinary drug metabolite testing in chronic heart failure patients indicates high levels of adherence with life‐prolonging therapies by Sweeney, Mark, Cole, Graham D., Pabari, Punam, Hadjiphilippou, Savvas, Tayal, Upasana, Mayet, Jamil, Chapman, Neil, Plymen, Carla M.

    Published in ESC Heart Failure (01-06-2021)
    “…Aims Despite medical therapy for heart failure (HF) having proven benefits of improving quality of life and survival, many patients remain under‐treated. This…”
    Get full text
    Journal Article
  14. 14

    Translating Stem Cell Research to Cardiac Disease Therapies by Rosen, Michael R., MD, Myerburg, Robert J., MD, Francis, Darrel P., MA, Cole, Graham D., MA, Marbán, Eduardo, MD, PhD

    “…Abstract Over the past 2 decades, there have been numerous stem cell studies focused on cardiac diseases, ranging from proof-of-concept to phase 2 trials. This…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials by Shun-Shin, Matthew J, Zheng, Sean L, Cole, Graham D, Howard, James P, Whinnett, Zachary I, Francis, Darrel P

    Published in European heart journal (07-06-2017)
    “…Primary prevention implantable cardioverter defibrillators (ICDs) are established therapy for reducing mortality in patients with left ventricular systolic…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Translating Stem Cell Research to Cardiac Disease Therapies: Pitfalls and Prospects for Improvement by ROSEN, Michael R, MYERBURG, Robert J, FRANCIS, Darrel P, COLE, Graham D, MARBAN, Eduardo

    “…Over the past 2 decades, there have been numerous stem cell studies focused on cardiac diseases, ranging from proof-of-concept to phase 2 trials. This series…”
    Get full text
    Journal Article